Global Pulmonary Drug Delivery Systems Market Growth 2023-2029

Global Pulmonary Drug Delivery Systems Market Growth 2023-2029

Pulmonary drug delivery systems are used to the treatment of various respiratory diseases like asthma and chronic obstructive pulmonary disease (COPD), delivering locally acting drugs directly to their site of action. Advantages of pulmonary drug delivery systems over oral drugs is the excellent capability of absorbing pharmaceuticals, due to the large absorptive surface area of lungs (approximately 70-140 m2 in adult humans having extremely thin absorptive mucosal membrane) and good blood supply.
LPI (LP Information)' newest research report, the “Pulmonary Drug Delivery Systems Industry Forecast” looks at past sales and reviews total world Pulmonary Drug Delivery Systems sales in 2022, providing a comprehensive analysis by region and market sector of projected Pulmonary Drug Delivery Systems sales for 2023 through 2029. With Pulmonary Drug Delivery Systems sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pulmonary Drug Delivery Systems industry.
This Insight Report provides a comprehensive analysis of the global Pulmonary Drug Delivery Systems landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pulmonary Drug Delivery Systems portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Pulmonary Drug Delivery Systems market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pulmonary Drug Delivery Systems and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pulmonary Drug Delivery Systems.
The global Pulmonary Drug Delivery Systems market size is projected to grow from US$ 2979.8 million in 2022 to US$ 4016.5 million in 2029; it is expected to grow at a CAGR of 4016.5 from 2023 to 2029.
The major players in global Pulmonary Drug Delivery Systems market include 3M, GSK, AstraZeneca, etc. The top 3 players occupy about 60% shares of the global market. Europe and North America are main markets, they occupy over 75% of the global market. Metered Dose Inhaler (MDI) is the main type, with a share over 60%. COPD is the main application, which holds a share over 50%.
This report presents a comprehensive overview, market shares, and growth opportunities of Pulmonary Drug Delivery Systems market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Nebulizers
Dry Powder Inhaler (DPI)
Metered Dose Inhaler (MDI)
Segmentation by application
COPD
Asthma
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
3M
GSK
AstraZeneca
Cipla
Chiesi
Boehringer Ingelheim
Aptar
Novartis
Philips Respironics
Omron Healthcare
PARI
Skyepharma
CareFusion
Shanghai Huarui
Taian Character
Chia Tai Tianqing
Key Questions Addressed in this Report
What is the 10-year outlook for the global Pulmonary Drug Delivery Systems market?
What factors are driving Pulmonary Drug Delivery Systems market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pulmonary Drug Delivery Systems market opportunities vary by end market size?
How does Pulmonary Drug Delivery Systems break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.